Form 10-Q Akers Biosciences Inc For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Akers Biosciences (AKER) Reports Q3 Loss of $0.45/Share
November 13, 2015 7:08 AM ESTAkers Biosciences (NASDAQ: AKER) reported Q3 EPS of ($0.45), versus ($0.23) reported last year. Revenue for the quarter came in at $169.5 thousand, versus $453.3 thousand reported last year.
For earnings history and earnings-related data on Akers Biosciences (AKER) click here.
... More